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AbstrAct
Introduction Currently, the detection of pathogens or 
mutations associated with intraocular lymphomas heavily 
relies on prespecified, directed PCRs. With metagenomic 
deep sequencing (MDS), an unbiased high-throughput 
sequencing approach, all pathogens as well as all 
mutations present in the host’s genome can be detected 
in the same small amount of ocular fluid.
Methods In this cross-sectional case series, aqueous 
fluid samples from two patients were submitted to MDS 
to identify pathogens as well as common and rare cancer 
mutations.
results MDS of aqueous fluid from the first patient 
with vitreal lymphoma revealed the presence of both 
Epstein-Barr virus (HHV-4/EBV) and human herpes virus 
8 (HHV-8) RNA. Aqueous fluid from the second patient 
with intraocular B-cell lymphoma demonstrated a less 
common mutation in the MYD88 gene associated with 
B-cell lymphoma.
conclusion MDS detects pathogens that, in some 
instances, may drive the development of intraocular 
lymphomas. Moreover, MDS is able to identify both 
common and rare mutations associated with lymphomas.
IntroductIon
Molecular diagnostics such as pathogen-directed 
PCRs previously revolutionised the field of ophthal-
mology by accurately providing diagnoses for 
ocular infections using minute amounts of ocular 
samples.1 2 A major limitation with these assays is 
that only prespecified pathogens can be detected 
leading to potential missed pathogens. Additionally, 
directed PCR or DNA microarray may overlook 
less common mutations associated with lymphopro-
liferative disorders. Metagenomic deep sequencing 
(MDS) is an unbiased high-throughput sequencing 
approach that can theoretically detect all patho-
gens in a clinical sample. Further, it simultaneously 
provides genetic information that may be useful for 
evaluating the host’s immune system. Distinguishing 
uveitis as infectious or non-infectious is vital as such 
knowledge guides appropriate treatment. It is also 
important to identify uveitic masqueraders such as 
intraocular malignancies as the treatment is likewise 
impacted by this knowledge. Herein, we present 
two cases of intraocular lymphoproliferative disor-
ders that were identified using MDS.
Methods
study design
Cross-sectional case studies in which patients’ 
aqueous fluid samples were submitted to MDS 
to identify infectious pathogens as well as host 
genome sequencing to identify mutations asso-
ciated with lymphoproliferative disorders. Our 
research adhered to the tenets of the Declaration 
of Helsinki. Informed consent was obtained from 
all participants.
sequencing library preparation
Samples were prepared for MDS as previously 
described.3 4 Briefly, RNA was extracted from 20 
to 50 µL of aqueous fluid with the Direct-zol RNA 
Microprep (Zymo Research, California, USA) 
per manufacturer’s recommendations and eluted 
in 20 µL nuclease-free water. Five microlitres of 
the extracted RNA were used to prepare libraries 
using the New England Biolabs’ (NEB) NEBNext 
RNA First Strand Synthesis Module (E7525) and 
NEBNext Ultra Directional RNA Second Strand 
Synthesis Module (E7550) to generate double-
stranded cDNA. The cDNA was converted to Illu-
mina libraries using the NEBNext Ultra II DNA 
Library Prep Kit (E7645) according to the manu-
facturer’s recommendation and then amplified 
with 14 PCR cycles. Samples were sequenced on 
the Illumina HiSeq 4000 using 125-nucleotide (nt) 
paired-end sequencing.
bioinformatics
Analysis of sequenced data was made using a 
rapid computational pipeline developed in-house 
to classify sequencing reads and identify potential 
pathogens against the entire National Center for 
Biotechnology Information (NCBI) nt reference 
database.3 4 To identify the somatic mutations in 
the myeloid differentiation primary response 88 
(MYD88) gene (NC_000003.12), we aligned the 
filtered human sequences against the MYD88 gene 
using HISAT2 (V.2.0.5).5
results
The first patient was a middle-aged Caucasian man 
who presented with ‘foggy vision’ in the left eye. 
His medical history included Kaposi sarcoma of the 
chest and thigh 30 years ago and now in remission, 
and a diagnosis of HIV 15 years prior, currently on 
antiretroviral treatment. His most recent absolute 
CD4 count was 800×106/L. Examination of the 
right eye was unremarkable. Notably, the left eye 
exhibited ½+ anterior chamber cells and 1+ flare, 
3+ vitreous cells and ½+ vitreous haze (figure 1A). 
There were no retinal or choroidal lesions. Ante-
rior chamber paracentesis was performed as well as 
a diagnostic and therapeutic vitrectomy of the left 
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Figure 1 Clinical, histopathology and metagenomic deep sequencing (MDS) findings of patient #1 and #2. (A) Anterior vitreous cells on slit lamp 
examination, and (B) HHV-8 and HHV-4 (also known as EBV) genomes were detected in the aqueous fluid by MDS for patient #1; (C) photomicrograph 
of H&E-stained specimen from the anterior chamber biopsied material disclosing the presence of numerous intermediate to large cells with irregular 
nuclei. Immunohistochemistry of these cells showed diffusely positive staining with B-lymphocyte antigen CD20 and most of the large cells stained 
positively with BCL-2 (not shown), and (D) analysis of the MYD88 gene indicated the presence of a serine to asparagine mutational change at amino 
acid position 243 for patient #2. (E) Phylogenetic analysis of the HHV-8 sequence obtained from MDS for patient #1 using the ORF K1 hypervariable 
region with HHV-8 isolates from different diseases and geographic origins using multiple sequence comparison by log-expectation (MUSCLE).12 HHV-
8, human herpes virus-8; HHV-4, human herpes virus-4; EBV, Epstein-Barr virus; BCL-2, B-cell lymphoma 2; MYD88, myeloid differentiation primary 
response 88; ORF, open reading frame; BCBL, body cavity-based lymphoma.
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eye. Pathogen-directed PCR analysis of the aqueous fluid was 
negative for herpes simplex virus (HSV), varicella zoster virus 
(VZV) and cytomegalovirus (CMV). MDS of the aqueous fluid 
identified the presence of both Epstein-Barr virus (HHV-4/EBV) 
and human herpes virus 8 (HHV-8) RNA (figure 1B). The vitrec-
tomy fluid yielded rare, small lymphocytes on cytopathology, 
no B-cells on flow cytometry, but Ig-kappa gene rearrangement 
suggestive of lymphoma. In the context of a patient with HIV, 
the finding of lymphoma with a coinfection with HHV-8 and 
EBV can be associated with a phenotype most similar to primary 
effusion lymphoma (PEL).6 Interestingly, phylogenetic analysis 
of the patient’s HHV-8 strain indicated that it was most similar 
to a PEL-associated strain isolated from a patient in the USA 
(NCBI GenBank AF1330391.1, figure 1E).
The second patient was a mid-30s Caucasian man with bilat-
eral intermediate uveitis of 5 years’ duration who presented for 
initiation of systemic immunomodulatory therapy. A vitrectomy 
performed 1 year after onset of disease showed mixed lympho-
cytes, but was read as negative for lymphoma. On presentation 
in our clinic, the patient exhibited 1+ anterior chamber cells, 3+ 
anterior vitreous cells and 1+ vitreous haze in the right eye. The 
left eye had no anterior chamber cell or flare, but with 3+ ante-
rior vitreous cells and no vitreous haze. There were no retinal or 
choroidal lesions in either eye. An anterior chamber paracentesis 
was negative on directed PCR for HSV, VZV, CMV and Toxo-
plasma gondii. Likewise, MDS was negative for infectious agents. 
Given that MDS captures mostly host sequence, we were able to 
use the same data set to interrogate the MYD88 gene for both 
common and rare mutations associated with lymphoma. Indeed, 
the patient exhibited the S243N mutation (figure 1D), which has 
been associated with the activated B-cell (ABC) subtype of diffuse 
large B-cell lymphoma. S243N is a recognised gain of function 
mutant that can contribute to constitutive NF-kB expression.7 
This finding was intriguing as 50%–70% of primary vitreoret-
inal lymphomas exhibit the L265P mutation.8 Thus, routine 
screening using directed PCR for the most common mutation 
would not have identified this patient’s lymphoma. A definitive 
diagnosis of lymphoma was provided when biopsy of material in 
the anterior chamber revealed large B-cell lymphoma on histo-
pathology (figure 1C).
dIscussIon
Intraocular lymphomas are challenging to diagnose given the 
small amounts of tissue that can be obtained on biopsy. Lympho-
matous cells are fragile and may appear as non-diagnostic 
‘smudge cells’ on cytopathological inspection.9 10 Further, the 
time of disease onset to diagnosis is often prolonged because 
its clinical signs may be attributed to undifferentiated uveitis.11 
The cases described here demonstrated that MDS can accurately 
detect pathogen-related causes of inflammation that drive intra-
ocular lymphomas as well as common and rare cancer-associ-
ated mutations in as little as 20 to 50 µL of aqueous fluid. MDS, 
therefore, has the potential to improve the diagnostic rates of 
intraocular lymphomas as the diagnosis may be possible with 
a single outpatient anterior chamber paracentesis as the initial 
work-up.
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